Ivan Bassanini
Overview
Explore the profile of Ivan Bassanini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tonelli M, Sparatore A, Bassanini I, Francesconi V, Sparatore F, Maina K, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770510
Four years after the COVID-19 pandemic, a very limited number of drugs has been marketed; thus, the search for new medications still represents a compelling need. In our previous work...
2.
Kurt H, Akyol A, Son C, Zheng C, Gado I, Meli M, et al.
bioRxiv
. 2024 Dec;
PMID: 39713392
G protein-coupled receptor (GPCR) signaling is terminated by arrestin binding to a phosphorylated receptor. Binding propensity has been shown to be modulated by stabilizing the pre-activated state of arrestin through...
3.
Bassanini I, Tognoli C, Meli M, Parapini S, Basilico N, Fronza G, et al.
Bioorg Chem
. 2024 Oct;
153:107917.
PMID: 39476600
Leishmaniasis and malaria are two debilitating protozoan diseases affecting millions globally, particularly in tropical and subtropical regions. Current therapeutic options face significant challenges due to emerging drug-resistant strains, necessitating the...
4.
Artasensi A, Bassanini I, E Ferrandi E, Feni L, Vistoli G, Fumagalli L, et al.
Bioorg Chem
. 2023 Jun;
138:106675.
PMID: 37329813
As a rich source of biological active compounds, marine natural products have been increasingly screened as candidates for developing new drugs. Among the several marine products and metabolites, (+)-Harzialactone A...
5.
Bassanini I, Grosso S, Tognoli C, Fronza G, Riva S
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36834934
The bio-oxidation of a series of aromatic amines catalyzed by laccase has been investigated exploiting either commercially available nitrogenous substrates [()-4-vinyl aniline and diphenyl amine] or ad hoc synthetized ones...
6.
Ferrandi E, Bassanini I, Bertuletti S, Riva S, Tognoli C, Vanoni M, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293010
In a metagenome mining-based search of novel thermostable hydroxysteroid dehydrogenases (HSDHs), enzymes that are able to selectively oxidize/reduce steroidal compounds, a novel short-chain dehydrogenase/reductase (SDR), named Is2-SDR, was recently discovered....
7.
Bassanini I, Parapini S, Basilico N, Taramelli D, Romeo S
ChemMedChem
. 2022 Sep;
17(21):e202200355.
PMID: 36089546
To improve the metabolic stability of a 4,4'-oxybisbenzoyl-based novel and potent (nanomolar-range IC ) antiplasmodial agent previously described by us, in silico-guided structure-activity relationship (SAR) campaigns have been conducted to...
8.
Massironi A, Di Fonzo A, Bassanini I, Ferrandi E, Marzorati S, Monti D, et al.
Molecules
. 2022 Jul;
27(15).
PMID: 35897957
The valorization of biomass residuals constitutes a key aspect of circular economy and thus a major challenge for the scientific community. Among industrial wastes, plant residuals could represent an attractive...
9.
Stereoselective Biocatalyzed Reductions of Ginger Active Components Recovered from Industrial Wastes
Nasti R, Bassanini I, Ferrandi E, Linguardo F, Bertuletti S, Vanoni M, et al.
Chembiochem
. 2022 Feb;
23(8):e202200105.
PMID: 35188325
Ginger is among the most widespread and widely consumed traditional medicinal plants around the world. Its beneficial effects, which comprise e. g. anticancer and anti-inflammatory activities as well as gastrointestinal...
10.
Koval A, Bassanini I, Xu J, Tonelli M, Boido V, Sparatore F, et al.
Eur J Med Chem
. 2021 Jun;
222:113562.
PMID: 34116325
Triple-negative breast cancer (TNBC) is a cancer subtype critically dependent upon excessive activation of Wnt pathway. The anti-mycobacterial drug clofazimine is an efficient inhibitor of canonical Wnt signaling in TNBC,...